Felix Health Cost & Pricing

Last reviewed: May 16, 2026

Last updated: May 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Felix Health charges $149-$289/mo monthly for GLP-1 therapy through telehealth. Cost varies by medication strength, subscription tier, and membership model. Understanding pricing structures across providers is essential for informed access decisions, especially when genetic and biomarker data can contextualize treatment value.

GLP-1 medication pricing reflects compounding quality, provider oversight, and pharmacy licensing. PlexusDx offers compounded semaglutide and tirzepatide from $149/mo through licensed 503A pharmacies. Cost alone does not predict efficacy; genetic predispositions and clinical markers may help patients evaluate which option aligns with their health profile and budget.

How GLP-1 Pricing Models Vary Across Providers

Telemedicine GLP-1 platforms typically bundle provider consultation, prescription, shipping, and follow-up into monthly subscription fees. Felix Health, Ro, Hims, and Noom all use tiered pricing based on medication type and dose strength. Compounded pharmacies like PlexusDx may offer lower entry costs because they source active ingredients differently than branded manufacturers.

Pricing transparency matters for long-term affordability. Some platforms charge enrollment fees or require minimum subscription lengths. PlexusDx compounded options start at $179/month for semaglutide and $229/month for tirzepatide, with no hidden enrollment surcharges, allowing patients to evaluate total cost of care upfront.

Cost Comparison Framework: Branded vs. Compounded GLP-1 Options

Branded GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) carry higher acquisition costs passed to patients through insurance copays or direct-pay pricing. Compounded formulations sourced from licensed 503A pharmacies offer cost savings while maintaining rigorous quality and pharmacy oversight. The table below compares typical cost structures and key differentiators across access models.

Access Model	Typical Monthly Cost	Pharmacy Type	Provider Oversight
Branded GLP-1 (Wegovy, Ozempic)	$129-$369/mo+	Licensed pharmacy (manufacturer)	Licensed MD/NP via telehealth or in-person
Compounded Semaglutide (PlexusDx)	$149	Licensed 503A compounding pharmacy	Licensed MD/NP; quarterly check-ins
Compounded Tirzepatide (PlexusDx)	$249	Licensed 503A compounding pharmacy	Licensed MD/NP; quarterly check-ins
Telehealth Bundled (Felix, Ro, Hims)	$149-$289/mo	Third-party fulfillment pharmacy	Telehealth provider; limited follow-up

Understanding True Cost of Care Beyond Monthly Fees

Monthly price tags do not capture full care costs. Branded medications may qualify for manufacturer assistance programs; compounded options may require labs or genetic testing to optimize outcomes. PlexusDx Precision Peptide Genetic Test ($99 add-on or $298 standalone) reveals genetic predispositions in peptide pathways, potentially reducing trial-and-error dosing and supporting provider decision-making.

Effective GLP-1 care includes baseline metabolic labs, ongoing provider communication, and dose adjustments. Patients may benefit from understanding their genetic predispositions in GIPR, GLP1R, FTO, and MC4R variants before starting therapy. This context-rich approach may reduce wasted medication cycles and improve perceived value for monthly investment.

Who Benefits Most From Cost-Effective GLP-1 Access and Genetic Context

Patients with modest insurance coverage, high deductibles, or no coverage benefit most from transparent, lower-cost compounded options. Those with family history of metabolic disorder, cardiovascular risk, or prior medication side effects may especially benefit from genetic predisposition insights before committing to a regimen. Qualified providers can use this information to guide dose escalation and formulation choice.

Safety considerations are paramount: GLP-1 suitability depends on renal function, thyroid history, pancreatitis risk, and medication interactions. Cost should never override clinical evaluation. Work with a licensed provider to confirm candidacy, baseline labs, and appropriate dosing—whether through PlexusDx compounded options or other platforms. Genetic insights support but do not replace medical judgment.

How PlexusDx Supports a More Personalized Approach

PlexusDx genetic testing reveals predispositions in key peptide-pathway variants (GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, MC4R rs17782313) that may help provide context for how an individual's metabolic and appetite-regulation pathways function. This information should be interpreted with a qualified healthcare provider to inform medication selection and dosing strategy—not to predict exact response.

The Precision Peptide Genetic Test does not predict which GLP-1 medication will work or guarantee weight loss. Instead, it offers predisposition data in genetic pathways relevant to GLP-1 mechanism of action. Combined with biomarkers (fasting glucose, insulin, lipids), genetic insights can support a more personalized conversation between patient and provider about treatment expectations and cost-value alignment.

When evaluating monthly cost across providers like Felix Health and PlexusDx, consider total care: medication price, provider oversight, genetic context, and follow-up frequency. A lower monthly fee paired with genetic predisposition data and regular provider communication may deliver stronger outcomes than cost alone. Discuss genetic testing and biomarker interpretation with your provider to optimize treatment value.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose Glp1 Protocol starts at $129/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How does Felix Health's $149-$289/mo monthly cost compare to PlexusDx pricing?

Felix charges $149-$289/mo monthly; PlexusDx compounded semaglutide starts at $149/mo and tirzepatide at $249/mo. Both include provider oversight. PlexusDx uses licensed 503A pharmacies; exact pricing varies by formulation and dose strength chosen with your provider.

Do lower-cost GLP-1 options offer the same clinical efficacy as branded medications?

Compounded GLP-1 active ingredients are equivalent in strength to branded formulations when sourced from licensed pharmacies. Clinical outcomes depend on dose, adherence, lifestyle, and individual metabolism—not whether medication is branded or compounded. Provider oversight is essential for safety and efficacy regardless of cost.

Can genetic testing help me decide if GLP-1 cost is worth the investment?

PlexusDx Precision Peptide Genetic Test reveals predispositions in GLP-1 pathway genes, which may help contextualize treatment potential with your provider. Genetic insights do not guarantee outcomes but can support informed cost-benefit discussion and personalized dose planning.

Are there hidden costs I should expect with PlexusDx or other telemedicine GLP-1 platforms?

PlexusDx has transparent pricing with no enrollment or hidden fees. Monthly cost covers medication and basic provider access. Some platforms charge extra for labs, genetic testing, or expedited shipping. Ask about the full cost breakdown before enrolling in any service.

Should I choose GLP-1 based purely on monthly cost, or are other factors important?

Cost matters, but provider oversight, pharmacy licensing (503A vs. 503B), genetic predisposition context, and personalized dosing support long-term value. The cheapest option may not deliver best outcomes if it lacks clinical guidance. Discuss cost, biomarkers, and genetic factors with a qualified provider to align treatment with your health goals.

Felix Health Cost: Biomarker-Guided Pricing and Personalized Access